Approvals (Drugs@FDA)

DOXYCYCLINE HYCLATE

SUN PHARM INDUSTRIES · DOXYCYCLINE HYCLATE

ANDA062677Generic (ANDA)Prescription
Open FDA's page for this record
Application number
ANDA062677
Sponsor name
SUN PHARM INDUSTRIES
Submissions
  1. Submission type
    SUPPL
    Submission number
    41
    Submission status
    AP
    Submission status date
    20150910
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
  2. Submission type
    SUPPL
    Submission number
    17
    Submission status
    AP
    Submission status date
    20030401
    Submission class code
    LABELING
    Submission class code description
    Labeling
  3. Submission type
    SUPPL
    Submission number
    13
    Submission status
    AP
    Submission status date
    20010412
    Submission class code
    MANUF (CMC)
    Submission class code description
    Manufacturing (CMC)
  4. Submission type
    SUPPL
    Submission number
    8
    Submission status
    AP
    Submission status date
    19970224
    Submission class code
    MANUF (CMC)
    Submission class code description
    Manufacturing (CMC)
  5. Submission type
    SUPPL
    Submission number
    11
    Submission status
    AP
    Submission status date
    20000516
    Submission class code
    MANUF (CMC)
    Submission class code description
    Manufacturing (CMC)
  6. Submission type
    SUPPL
    Submission number
    6
    Submission status
    AP
    Submission status date
    19940112
    Submission class code
    MANUF (CMC)
    Submission class code description
    Manufacturing (CMC)
  7. Submission type
    SUPPL
    Submission number
    4
    Submission status
    AP
    Submission status date
    19930326
    Submission class code
    LABELING
    Submission class code description
    Labeling
  8. Submission type
    ORIG
    Submission number
    1
    Submission status
    AP
    Submission status date
    19860710
  9. Submission type
    SUPPL
    Submission number
    46
    Submission status
    AP
    Submission status date
    20180515
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
  10. Submission type
    SUPPL
    Submission number
    50
    Submission status
    AP
    Submission status date
    20180515
    Review priority
    STANDARD
    Submission class code
    LABELING
    Submission class code description
    Labeling
  11. Submission type
    SUPPL
    Submission number
    28
    Submission status
    AP
    Submission status date
    20060928
    Submission class code
    LABELING
    Submission class code description
    Labeling
  12. Submission type
    SUPPL
    Submission number
    34
    Submission status
    AP
    Submission status date
    20111130
    Submission class code
    LABELING
    Submission class code description
    Labeling
  13. +18 more not shown
Products
  1. Product number
    001
    Reference drug
    No
    Brand name
    DOXYCYCLINE HYCLATE
    Reference standard
    No
    Dosage form
    TABLET
    Route
    ORAL
    Marketing status
    Prescription
    Te code
    AB
    Active ingredients
    1. Name
      DOXYCYCLINE HYCLATE
      Strength
      EQ 100MG BASE
Harmonized identifiers (openFDA)
Application number
ANDA062677
Brand name
DOXYCYCLINE HYCLATE
Generic name
DOXYCYCLINE HYCLATE
Manufacturer name
Sun Pharmaceutical Industries, Inc.
Product NDC
53489-120, 53489-118, 53489-119
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
DOXYCYCLINE HYCLATE
RxCUI
1649405, 1649988, 1650143
SPL ID
53577734-d479-e32b-e063-6394a90a7933
SPL set ID
214a9cfe-a522-4022-81d4-e59f447401fe
Package NDC
53489-118-02, 53489-118-05, 53489-119-02, 53489-119-05, 53489-120-02, 53489-120-05, 53489-120-60, 53489-120-01
UNII
19XTS3T51U
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Join as a DoctorSell on MedGrid

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.